Go to deals
Agriculture | Food & Beverage | Private Equity

The Kraft Heinz Company has sold Heinz Italia's Parma plant to The Newlat Group

The Newlat Group has acquired Kraft Heinz’s Italian infant food and nutraceuticals production plant. The financial terms of the transaction have not been disclosed.

The Parma-based plant, owned by the Italian division of US food giant Kraft Heinz, produces the well-known Plasmon biscuits as well as pasta, liquid milk, dry milk and cereals, among other products. The site also produces foods under the brands Nipiol, BiAglut, Aproten and Dieterba. The plant has an estimated production capacity of approximately 20,000 tons. It is equipped with high quality milk production lines in addition to gluten-free and aproteic certified pasta production lines.

The Newlat Group is one of the top ten players in the Italian food sector, with a turnover exceeding US$355 million. Its business is focused on milk and wheat-based products, with an existing base of 11 production plants. With this acquisition, Newlat adds baby food as well as gluten-free and aproteic products to its business as well as increased access to international markets.

The Kraft Heinz Company is one of the most renowned food multinationals in the world, with a turnover of over US$12 billion and more than 24,000 employees.

Oaklins' team in Italy acted as the exclusive M&A advisor to Kraft Heinz throughout the entire divestment process.

Parties

Talk to the deal team

Giuseppe Maria Bernardo Puccio

Principal
Milan, Italy
Oaklins Italy

Related deals

Den Berk Délice accelerates growth through strategic partnership
Private Equity | Agriculture

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Learn more
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Healthcare

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Learn more
Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida
Private Equity | Financial Services

Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida

Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.

Learn more